September 22, 2023 Late-stage biopharmaceutical company, SELLAS Life Sciences Group, Inc. (Nasdaq: SLS) has announced positive topline data for the patient group with relapsed/refractory (r/r) lymphomas from its Phase 1 dose-escalation trial of its CDK9 inhibitor, SLS009 (GFH009). “We are excited to share strong topline data from the Phase 1 trial of SLS009 in lymphoma patients. The … Continue reading “SELLAS SLS009 Phase 1 Clinical Study Successfully Achieves All Primary and Secondary Endpoints”
Breaking News
SKYX Platforms (SKYX) Increases Patent Count With Five Additional Issued in US and International
September 22, 2023 Today SKYX Platforms (SKYX) has announced the issuance of five new utility patents in…
Allied Energy Corp Enters Groundbreaking Joint Venture with Enegix Global, One of the World’s Leading Bitcoin Mining hosting providers
Carrollton, Texas, September 20, 2023 – Allied Energy Corp (OTC: AGYP), an innovative oil and…
LEARNINGQ LAUNCHES SEPTEMBER 1, 2023 AFTER RECEIVING TWO FEDERAL GRANTS THROUGH THE NATIONAL INSTITUTE ON DISABILITY, INDEPENDENT LIVING, AND REHABILITATION RESEARCH’S (NIDILRR) SMALL BUSINESS INNOVATION RESEARCH (SBIR) PROGRAM
CHICAGO, IL, September 20, 2023 – On September 1, 2023, LearningQ officially launched two new…
XA Interactive Embraces ESP Techniques, Begins New Drilling Operations To Boost Production
ORLANDO, FL, September 20, 2023 – Holiday Island Holdings, Inc. (OTC PINK: HIHI) recently completed…
Seminario Web gratuito “Desalination Latin America: Progress of Key Projects”
Organizador: Vostock Capital Preámbulo a la 6ta Conferencia y Exposición Internacional DESALINIZACIÓN AMÉRICA LATINA 2024,…
Free webinar “Desalination Latin America: Progress of Key Projects”
Organiser: Vostock Capital Prior to the 6th International Conference and Exhibition DESALINATION LATIN AMERICA 2024,…
NATURAL HARMONY FOODS INC. ANNOUNCES NEW STRATEGIC DIRECTION AND SETS THE STAGE FOR A REVOLUTION IN HEALTHCARE AND WELLNESS
NEW YORK, NY, September 19, 2023 -Publicly-held Natural Harmony Foods, Inc. (OTC: NHYF) (the Company)…
BioStem Technologies Initiates Nationwide Launch of AmnioWrap2™ with Venture Medical
Leading wound market solutions provider will lead BioStem’s commercialization of AmnioWrap2™ AmnioWrap2 is a versatile…
SKYX Appoints Widely-Respected Public Financial Markets Authority, Lenny Sokolow as Co-CEO
“I can’t emphasize enough how excited I am to join SKYX and introduce its growth…
MetatronAI.com: Revolutionizing Content Creation with Speed and Savings, Plus a Glimpse of the Future with Text-to-Video Service
Dover, DE, September 18, 2023 – Metatron Apps Inc., (OTC: MRNJ) a trailblazer in AI-driven…
BioStem Technologies Engages PCG Advisory for Strategic Investor Relations
POMPANO BEACH, FLORIDA, September 18, 2023 – BioStem Technologies Inc. (OTC: BSEM), an innovator in…
XA Interactive Secures Funding to Expand Oil Drilling Operations
ORLANDO, FL, September 18, 2023 – Holiday Island Holdings, Inc. (OTC PINK: HIHI) recently completed…
Oncocyte’s VitaGraftTM Kidney Identifies Transplant Rejection 10 Months Earlier
Interventional study compares VitaGraft to current transplant rejection monitoring protocols Oncocyte’s VitaGraft assay detects antibody-mediated…